🇺🇸 ipratropium plus salbutamol UDV in United States

ipratropium plus salbutamol UDV (ipratropium plus salbutamol UDV) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

ipratropium plus salbutamol UDV in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ipratropium plus salbutamol UDV approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for ipratropium plus salbutamol UDV in United States?

Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.